|
81
|
301
|
9aulA |
Structure of sars-cov-2 mpro mutant (a173v,t304i)) in complex with nirmatrelvir (pf-07321332) |
|
89
|
302
|
9aukA |
Structure of sars-cov-2 mpro mutant (a173v) in complex with nirmatrelvir (pf-07321332) |
|
88
|
302
|
9aumA |
Structure of sars-cov-2 mpro mutant (t21i,s144a,t304i) in complex with nirmatrelvir (pf-07321332) |
|
77
|
306
|
9auoA |
Structure of sars-cov-2 mpro mutant (l50f,t304i) |
|
81
|
306
|
9aunA |
Structure of sars-cov-2 mpro mutant (t21i,t304i) |
|
88
|
304
|
9booA |
Crystal structure of mers-cov nsp5 in complex with pf-07817883 |
|
84
|
301
|
8cacAAA |
Crystal structure of sars-cov-2 mpro-h172y mutant in complex with 13b-k |
|
86
|
301
|
8vqxA |
Structure of sars-cov-2 main protease with potent peptide aldehyde inhibitor |
|
86
|
302
|
8ca8AAA |
Crystal structure of sars-cov-2 mpro-h172y mutant, free enzyme |
|
82
|
305
|
8c9pAAA |
Crystal structure of sars-cov-2 mpro-e166v mutant, free enzyme |
|
81
|
301
|
9fx7A |
Crystal structure of cryo2rt sars-cov-2 main protease at 294k |
|
87
|
301
|
9fx6A |
Crystal structure of cryo2rt sars-cov-2 main protease at 100k |
|
88
|
306
|
8vd7A |
Microed structure of sars-cov-2 main protease (mpro/3clpro) with missing cone eliminated by suspended drop |
|
87
|
306
|
9attA |
Crystal structure of mers 3cl protease in complex with a methylcyclohexyl 2-pyrrolidone inhibitor (r-enantiomer) |
|
89
|
300
|
9at1A |
Crystal structure of sars-cov-2 3cl protease in complex with a methylcyclohexyl 2-pyrrolidone inhibitor (r-enantiomer) |
|
86
|
305
|
9ateA |
Crystal structure of mers 3cl protease in complex with a methylbicyclo[2.2.1]heptane 2-pyrrolidone inhibitor |
|
85
|
306
|
9atgA |
Crystal structure of mers 3cl protease in complex with a 2,2-difluoro-5-methylbenzo[1,3]dioxole 2-pyrrolidone inhibitor |
|
86
|
305
|
9athA |
Crystal structure of mers 3cl protease in complex with a methylbicyclo[2.2.1]heptene 2-pyrrolidone inhibitor |
|
84
|
298
|
9aswA |
Crystal structure of sars-cov-2 3cl protease in complex with a m-fluorobenzyl 2-pyrrolidone inhibitor |
|
88
|
299
|
9at0A |
Crystal structure of sars-cov-2 3cl protease in complex with a methylcyclohexyl 2-pyrrolidone inhibitor (s-enantiomer) |
|
85
|
300
|
9at4A |
Crystal structure of sars-cov-2 3cl protease in complex with a methylbicyclo[2.2.1]heptane 2-pyrrolidone inhibitor |
|
88
|
300
|
9aszA |
Crystal structure of sars-cov-2 3cl protease in complex with a phenylethyl 2-pyrrolidone inhibitor |
|
84
|
300
|
9asvA |
Crystal structure of sars-cov-2 3cl protease in complex with a benzyl 2-pyrrolidone inhibitor |
|
85
|
299
|
9asyA |
Crystal structure of sars-cov-2 3cl protease in complex with a m-chlorobenzyl 2-pyrrolidone inhibitor |
|
83
|
298
|
9at3A |
Crystal structure of sars-cov-2 3cl protease in complex with an ethylcyclohexyl 2-pyrrolidone inhibitor |
|
84
|
305
|
9atiA |
Crystal structure of mers 3cl protease in complex with a racemic bicyclo[2.2.1]heptenyl-methyl 2-pyrrolidone inhibitor |
|
85
|
305
|
9atfA |
Crystal structure of mers 3cl protease in complex with a 1-methyl-4,4-difluorocyclohexyl 2-pyrrolidone inhibitor |
|
85
|
306
|
9atdA |
Crystal structure of mers 3cl protease in complex with a ethylcyclohexyl 2-pyrrolidone inhibitor (s-enantiomer) inhibitor |
|
88
|
306
|
9ataA |
Crystal structure of mers 3cl protease in complex with a phenylethyl 2-pyrrolidone inhibitor |
|
85
|
303
|
9at6A |
Crystal structure of sars-cov-2 3cl protease in complex with a methylbicyclo[2.2.1]heptene 2-pyrrolidone inhibitor |
|
82
|
306
|
9atsA |
Crystal structure of mers 3cl protease in complex with a methylcyclohexyl 2-pyrrolidone inhibitor (s-enantiomer) |
|
84
|
303
|
9at5A |
Crystal structure of sars-cov-2 3cl protease in complex with a 1-methyl-4,4-difluorocyclohexyl 2-pyrrolidone inhibitor |
|
88
|
301
|
9at7A |
Crystal structure of sars-cov-2 3cl protease in complex with a 2,2-difluoro-5-methylbenzo[1,3]dioxole 2-pyrrolidone inhibitor |
|
86
|
305
|
9atjA |
Crystal structure of mers 3cl protease in complex with a m-chlorobenzyl 2-pyrrolidone inhibitor |
|
83
|
296
|
8yrhA |
Complex of sars-cov-2 main protease and rosmarinic acid |
|
84
|
306
|
7shbA |
Structure of the sars-cov-2 main protease in complex with inhibitor mpi79 |
|
78
|
300
|
8qdcA |
Crystal structure of sars-cov-2 main protease (mpro) in complex with the covalent inhibitor gue-3642 (compound 1 in publication) |
|
78
|
305
|
8t7yA |
Structure of sars cov-2 main protease in complex with chymostatin. |
|
88
|
306
|
8k67A |
Crystal structure of sars-cov-2 3clpro m165v mutant |
|
0
|
9
|
8v8eC |
Room-temperature x-ray structure of sars-cov-2 main protease catalytic domain (residues 1-199-6h) in complex with ensitrelvir (esv) |
|
82
|
306
|
8k6cA |
Crystal structure of sars-cov-2 3clpro m49k/s301p mutant |
|
82
|
301
|
8k6dA |
Crystal structure of sars-cov-2 3clpro m49k/s301p mutant in complex with wu-04 |
|
85
|
304
|
8k6bA |
Crystal structure of sars-cov-2 3clpro m49k/m165v mutant |
|
47
|
185
|
8v8eA |
Room-temperature x-ray structure of sars-cov-2 main protease catalytic domain (residues 1-199-6h) in complex with ensitrelvir (esv) |
|
75
|
301
|
8rjyA |
Crystal structure of sars-cov-2 main protease (mpro) in complex with the covalent inhibitor gue-3899 (compound 58 in publication) |
|
81
|
305
|
8rjvA |
Crystal structure of sars-cov-2 main protease (mpro) in complex with the covalent inhibitor gue-3778 (compound 12 in publication) |
|
48
|
185
|
8v8gA |
Room-temperature x-ray structure of sars-cov-2 main protease catalytic domain (residues 1-196) in complex with ensitrelvir (esv) |
|
88
|
302
|
8rjzA |
Crystal structure of sars-cov-2 main protease (mpro) in complex with the non-covalent inhibitor gue-3801 (compound 80 in publication) |
|
75
|
305
|
9hdcA |
Sars-cov-2 main protease in complex with (3s)-3-[(3r)-3-phenylpiperidine-1-carbonyl]indan-1-one |
|
80
|
305
|
9hc1A |
Sars-cov-2 main protease complexed with (1r)-n-(3-chlorophenyl)-3-oxo-n-[4-(2-oxopyrrolidin-1-yl)phenyl]indane-1-carboxamide |
